Asia Pacific Atopic Dermatitis Drugs Market Size & Outlook

The atopic dermatitis drugs market in Asia Pacific is expected to reach a projected revenue of US$ 7,565.5 million by 2030. A compound annual growth rate of 11.2% is expected of Asia Pacific atopic dermatitis drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$3,949.8
Forecast, 2030 (US$M)
$7,565.5
CAGR, 2025 - 2030
11.2%
Report Coverage
Asia Pacific

Asia Pacific atopic dermatitis drugs market, 2018-2030 (US$M)

Asia

Asia Pacific atopic dermatitis drugs market highlights

  • The Asia Pacific atopic dermatitis drugs market generated a revenue of USD 3,949.8 million in 2024.
  • The market is expected to grow at a CAGR of 11.2% from 2025 to 2030.
  • In terms of segment, biologics was the largest revenue generating drug class in 2024.
  • PDE4 Inhibitors is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 3,949.8 million
Market revenue in 2030USD 7,565.5 million
Growth rate11.2% (CAGR from 2025 to 2030)
Largest segmentBiologics
Fastest growing segmentPDE4 Inhibitors
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCorticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics
Key market players worldwidePfizer Inc, Sanofi SA, AbbVie Inc, Galderma Group AG Registered Shares, Eli Lilly and Co, Regeneron Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Novartis AG ADR, Incyte Corp, LEO Pharma

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.4% of the global atopic dermatitis drugs market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 7,565.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Atopic Dermatitis Drugs Market Companies

Name Profile # Employees HQ Website

Asia Pacific atopic dermatitis drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.


Biologics was the largest segment with a revenue share of 46% in 2024. Horizon Databook has segmented the Asia Pacific atopic dermatitis drugs market based on corticosteroids, calcineurin inhibitors, pde4 inhibitors, biologics covering the revenue growth of each sub-segment from 2018 to 2030.


The atopic dermatitis drugs market in Asia Pacific is driven by increasing emphasis on demand for better healthcare and improving economic status of countries. Among all regions, the market in this region is expected to exhibit the fastest CAGR of 14.1% during the forecast period.

Increase in pro-health initiatives, adoption of better treatments, and rise in consumer awareness are driving market growth in this region. In addition, rising prevalence of atopic dermatitis, increasing demand for cost-effective treatment, and growing population significantly contribute to market growth.

Asia Pacific markets, such as China, Australia, Korea, and Taiwan, already have healthcare reimbursement systems that provide inclusive coverage for molecular diagnostic tests. Major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are some of the primary growth drivers of this market.

Reasons to subscribe to Asia Pacific atopic dermatitis drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific atopic dermatitis drugs market databook

  • Our clientele includes a mix of atopic dermatitis drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific atopic dermatitis drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific atopic dermatitis drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific atopic dermatitis drugs market size, by country, 2018-2030 (US$M)

Asia Pacific Atopic Dermatitis Drugs Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific atopic dermatitis drugs market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more